Sanofi's Genzyme Recalls Transplant Drug After Stability Test Failure

Sanofi is reporting another manufacturing problem, this time at one of the plants operated by its Genzyme subsidiary, causing it to recall a transplant-rejection drug. FiercePharma reports.